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a b s t r a c t
To investigate the role of NADPH oxidase homolog Nox1 at an early step of cell transformation, we utilized
human gingival mucosal keratinocytes immortalized by E6/E7 of human papillomavirus (HPV) type 16
(GM16) to generate progenitor cell lines either by chronic ethanol exposure or overexpression with Nox1.
Among several cobblestone epithelial cell lines obtained, two distinctive spindle cell lines – FIB and NuB1
cells were more progressively transformed exhibiting tubulogenesis and anchorage-independent growth
associated with increased invasiveness. These spindle cells acquired molecular markers of epithelial
mesenchymal transition (EMT) including mesenchymal vimentin and simple cytokeratins (CK) 8 and 18 as
well as myogenic alpha-smooth muscle actin and caldesmon. By overexpression and knockdown experi-
ments, we showed that Nox1 on a post-translational level regulated the stability of CK18 in an ROS-,
phosphorylation- and PKCepilon-dependent manner. PKCepilon may thus be used as a therapeutic target for
EMT inhibition. Taken together, Nox1 accelerates neoplastic progression by regulating structural intermediate
ﬁlaments leading to EMT of immortalized human gingival epithelial cells.
& 2013 The Authors. Published by Elsevier B.V. All rights reserved.
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Introduction
This mini-review illustrates our research approach to investigate
the role of NADPH oxidase homolog 1 (Nox1) in neoplastic progres-
sion of human epithelial cells. It is known that a direct tumorigenic
conversion of human epithelial cells to cancer phenotype is very
difﬁcult, and impossible to achieve in tissue cultures. Our experi-
mental designs described below have provided new insights that
Nox1 plays a role in regulation of epithelial mesenchymal transition
(EMT) on the molecular and functional levels.
Role of ROS and NADPH oxidases in epithelial cancers
The implication for reactive oxygen species (ROS) to play a role
in epithleial cancers has long been recognized based on the fact
that human cancer cells produce high levels of H2O2 [1], and
superoxide radical mediates neoplastic transformation of mouse
keratinocytes [2]. Data in the last 14 years have shown that the
sources of ROS in non-phagocytic epithelial cells are the homologs
of gp91phox, the catalytic subunit of the respiratory burst oxidase
of phagocytes, so-called Nox consisting of Nox1, Nox3, Nox4 and
Nox5 (while gp91phox is Nox2) [3,4]. These Nox proteins are 63–
65 kDa in size and show 20–60% sequence identity with one
another. The ﬁrst sequence of Nox cDNA from 3 laboratories was
all cloned from normal human colon initially called Mox1 (mito-
genic oxidase1) and later renamed as Nox1 [5–7].
Nox1, 2, 4, and 5 mRNAs are expressed in a variety of human
cancer cell lines indicating an association with cancer develop-
ment [3]. The role of Nox1 in cancer was ﬁrst shown by growth
stimulation and tumorigenic conversion of rodent NIH3T3 ﬁbro-
blasts upon Nox1 overexpression [5]. This tumorigenic phenotype
was reversed by overexpression of catalase indicating that H2O2
generated secondarily Nox1 serves as transformation signals [8].
Nox1 acting as a mitogenic oxidase was further conﬁrmed by data
showing Nox1 as a regulator of cyclin D1 [9], and that Nox1
produces H2O2 via Rac1 upon epidermal-growth-factor (EGF)
receptor ligation [10].
The role of Nox1 in human epithelial cancers was ﬁrst reported by
showing that overexpression of Nox1 increased tumorigenic poten-
tials of DU-145 human prostate cancer cell line [11]. While Nox1
mRNA is present in both primary and transformed human colonic
epithelial cells [12], Nox1 mRNA is detected only in human colon
tumors but not in ovarian, lymph, breast, prostate, lung, brain, and
melanoma tumors [13]. Nox1 is strongly expressed in gastric
adenocarcinomas, colonic adenomas and well differentiated adeno-
carcinomas [14], and breast and ovarian tumors [15]. However,
a study in human colon reported that Nox1 was constitutively
expressed in colonic epithelium but was not associated with colonic
tumorigenesis [16]. These data did not support the role of Nox1 in
cancer but rather in inﬂammation as Nox1 protein is also present in
lymphocytes in inﬂammatory bowel disease.
Setting up model human epithelial cells to study Nox1
functions
Transformation and tumorigenic conversion of mouse cells, such
as, keratinocytes [2] and ﬁbroblasts [5] could be accomplished in one
step by overexpression of an oncogene or oncogene-like such as
Nox1. Human epithelial cells are highly resistant to transformation
even after treatment with carcinogens [17,18]. Tumorigenic conver-
sion and transformation of human epithelial cells can be achieved in
a multi-step fashion, whereby immortalization is the critical step to
obtain tumorigenicity [19,20]. This accounts for the difﬁculties to
perform molecular studies on tumorigenic conversion of human
cells, and in fact many studies utilize carcinoma cell lines. In the latter
case, the mechanisms for an early stage of cell transformation cannot
be studied. Therefore, we had taken a step in choosing a non-cancer
immortalized cell line to study the role of Nox1 on phenotypic changes
associated with preneoplastic progression beyond immortalization.
It is known that HPV16E6 is able to immortalize human kerati-
nocytes [21], and confers resistance against radiation stress [22].
In our laboratory, we were able to successfully immortalize human
gingival mucosal (GM) keratinocytes with human papillomavirus
(HPV) type 16 E6/E7 oncogenes to generate a so-called GM16 cell line
[23]. Immortalization by HPV has been shown to be prerequisite for
progression of cell transformation elicited by subsequent exposure to
a carcinogen, such as, benzo(a)pyrene [24], asbestos [25], cisplatin
[26], and cigarette smoke condensate [27].
About the same time as the discovery of Nox1 [5], an earlier
biochemical characterization of ROS generation by human epithe-
lial cells was already described in human skin keratinocyte HaCaT
cells during growth-factor activation [28] and overexpression of
Ras [29]. In 2004, we accordingly have reported that HaCaT cells
express Nox1, Nox2, and Nox4 at mRNA levels, and that Nox1
appears to be the major gp91phox homolog expressed on the
protein level [30]. HaCaT cells carry genetic abnormalities from
spontaneous immortalization and were identiﬁed as pre-
transformed. HaCaT as an immortalized cell line proliferate in
standard DMEM. We showed that HaCaT cells expressed Nox1
protein more than GM16 keratinocytes which proliferate only in
low-calcium keratinocyte growth medium (KGM) [30].
Selection of preneoplastic human epithelial cells by
differentiation resistance
Defective terminal differentiation in cell cultures is regarded as a
consistent and selectable character of neoplastic human keratino-
cytes [31], and considered as an initiation of carcinogenesis [32].
In experiments using cultured cells, resistance against calcium-
induced terminal differentiation has been used for selection of
preneoplastic cells [33,34]. Indeed, preneoplastic cells induced by
Ras [33], HPV16E6 [34], or treatment of 12-O- tetradecanoylphorbol-
13-acetate (PMA) [35], exhibit an inhibition of terminal differentia-
tion. Therefore, we utilize a criterion in selecting cells that are
resistance against calcium-induced differentiation in our experiment.
Ethanol increases neoplastic progression of GM16 to cells
expressing Nox1
As HPV16-immortalized human epithelial cells have been used to
study tumorigenic potential of carcinogens [24–27], we were inter-
ested in whether ethanol could further neoplastic progression of
HPV16-immortalized gingival mucosal epithelial keraitnocytes. In
our ﬁrst study, we exposed GM16 cells to 30 mM ethanol in KGM a
closed small incubator with once per week ethanol replenishment
for 9 weeks [23]. Many cells were initially died off when cultured
medium was changed from KGM to standard high-calcium DMEM
containing 10% serumwithout ethanol. Few selectable cells persisted
and ﬁnally proliferated again to conﬂuent cultures. Upon further 15
passaging in DMEM, mixed population of cobblestone and elongated
progenitor cells were obtained. By differential trypsinization, two
distinct cell populations were obtained named as EPI and FIB cell
lines with epithelium-like cobblestone and elongated morphology,
respectively (Fig. 1A). These EPI and FIB cells selected to survive
ethanol-dependent stress and proliferating well in DMEM were
considered more transformed than the parental GM16 cells.
FIB cells were ﬁbroblast-like cells showing EMT also exhibited
anchorage-independent growth (AIG), and thus considered as
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more transformed than EPI cells [23,36]. FIB cells at passages o22
were able to revert back to EPI phenotype upon adaptation back to
KGM indicating that the phenotype was unstable at this stage [36].
Passaging FIB cells to passages 443 generated stable cells being
unable to revert back to cobblestone morphology. Subcutaneous
injection of EPI or FIB cells (at 60–70 passages) in nude mice did
not form tumors, thus they were in an intermediate benign stage,
but not yet tumorigenic as only FIB cells produced benign cysts
[36]. Using this cell model, we reported that the more transformed
FIB cells expressed increased Nox1 protein than less transformed
EPI [36]. In an NADPH-reconstituted assay, plasma membranes
isolated from FIB cells produced increased superoxide radical
adducts compared to those from EPI cells. Thus, Nox1 expression
is associated with cell transformation, i.e., elongated spindle
phenotype and AIG [36].
Furthermore, we showed that FIB cells expressed increased
levels of redox-sensitive inducible nitric oxide synthase (iNOS)
[37]. iNOS is shown to be associated with tumor invasiveness
consistent with increased iNOS at mRNA and protein levels in FIB
cells. The morphological reversion of FIB cells at low passages
upon adaptation to grow in KGM was associated with the reversal
of vimentin expression as well as AIG. Moreover, these revertants
showed reduced levels of iNOS mRNA as well as MAP kinase ERK and
phospho-ERK protein expression, while FIB cells without reversion
maintained the expression. The MEK1/2 inhibitor U0126 could
reduce detectable iNOS mRNA levels suggesting that MAP kinases
were upstream regulators of iNOS transcription. U0126 caused both
morphological and functional reversion of FIB cells indicating invol-
vement of MAP kinases in these functions [37].
Nox1 overexpression renders differentiation resistance for
selection of preneoplastic cells
To address a direct impact of Nox1 on cell transformation, we
performed transfection of GM16 cells with Nox1 plasmid [38].
In a similar manner as chronic ethanol treatment, we exposed
transfected cells to high-calcium DMEM for selection of preneo-
plastic cells following stationary conﬂuent cultures in low-calcium
KGM (Fig. 1B). In Nox1-transfected cells, we observed resistant
cells as small fast-dividing cells after exposure with DMEM and
serum for 7–10 days. These cells grew rapidly into empty spaces as
differentiated cells peeled off. After 3 weeks to allow conﬂuent
cultures, resistant cells could be passaged normally to obtain
Fig. 1. Experimental approaches in generation of selectable preneoplastic cell lines from GM16 cells. (A) Chronic treatment of GM16 cells with 30 mM ethanol produced
cobblestone EPI and ﬁbroblast-like FIB cells capable to proliferate in DMEM. The latter exhibited EMT with anchorage-independent growth. Phase contrast pictures show EPI
and FIB cells at passages 195–215 in DMEM. (B) Transfection with Nucleofection or Fugene 6 of GM16 cells with Nox1 plasmids under stationary cultures in KGM followed by
selection by high-calcium DMEM exposure. This, respectively, generated ﬁve NuB and FuB Nox1 cell lines capable of proliferating in DMEM. NuB1 cell line was the only line
with EMT, the rest of Nox lines were cobblestone cells. Phase contrast pictures show representative cobblestone FuB1 and NuB1 cells at passages 74–78 in DMEM.
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Nox lines. Unlike primary human keratinocytes, Nox1-expressing
HaCaT, EPI, and FIB cells proliferate in standard DMEM. This
made it possible for us to test whether Nox1 expression confers
resistance against differentiation induced by high calcium present
in DMEM and serum [31–35]. We were able to obtain ﬁve stable
Nox1 transfectants NuB1, FuB1, NuB2, FuB2, and NuB3 (named
according to Nucleofection or Fugene6 transfection method and
Batch number) (Fig. 1B). In the ﬁrst round of DMEM exposure, we
obtained NuB1 cell line which exhibited spindled EMT morphol-
ogy and acquired AIG. In subsequent rounds, the rest of the four
Nox1 transfectants produced cells with cobblestone morphology
(Fig. 1B).
Limitations and pitfalls of a method of preneoplastic selection
Selection of preneoplastic human cells in cultures has been
successfully utilized in oncogene- or HPV16-immortalized cells
[33,34] rendering them to be susceptible for neoplastic progres-
sion by carcinogens [24–27]. In our work, control experiments,
i.e., no ethanol treatment or control plasmid transfection were
performed in parallel. Without chronic ethanol treatment, we did
not obtain any progenitor cells. However, in control plasmid trans-
fection prolonged exposure in DMEM was necessary to generate
resistant cells which exhibited very slow growth rates at passages
o20, and became more proliferative at passages 420 [38]. These
cells were regarded as unusual cells which do not undergo
terminal differentiation in culture previously described in human
skin keratinocytes [39]. Thus, appropriate controls have to be
performed for testing overexpression of a proposed oncogene or
carcinogen. The limitations for selection in DMEM include an
extended length of time to remove dead cells, and that the
cultures should be kept stationary to near conﬂuence prior to
trypsinization. This may take as long as 3, 6 and 10 weeks for
Nox1-overexpresion experiments [38].
Gain of survival markers in selected preneoplastic cells
We further showed that preneoplastic cells by ethanol expo-
sure or Nox1 overexpression acquire increased cell survival mar-
kers. Cyclin kinase inhibitor p16INK4a is associated with by-pass
senescence and immortalization. Cyclin kinase complexation is
known to be altered by E6/E7 oncoproteins of HPV16, and thus
increases of p16INK4a are commonly observed in HPV16-containing
cancer tissues [21,23]. As shown in Fig. 2A, p16INK4a was upregu-
lated in NuB1 line compared with cobblestone cell lines and FIB
cells harvested at equivalent passages. Ethanol-induced resistant
EPI and FIB cells showed an upregulation of p16INK4a compared
with parental GM16 cells [23]. Protein expression of another cyclin
kinase inhibitor p27KIP1 was increased in NuB1 cells compared
with cobblestone cells [40]. Survivin is a protein in a family of
inhibitor of apoptosis protein (IAP), and its increased expression is
associated with early stage of transformation, and during devel-
opment of malignancy. NuB1 line expressed increased survivin
protein compared with other Nox1 cobblestone lines (Fig. 2A).
In a similar manner, NuB1 cells expressed increased cIAP-1, cIAP-2
as well as anti-apoptosis family member Bclx, and Bcl-2 proteins
compared with cobblestone Nox lines [40]. Our data hence provide
an evidence for survival advantage of spindle ﬁbroblast-like cells
over cobblestone cells.
We analyzed expression of Nox-based adapter proteins in our
cell lines [41–43]. Nox1-derived cell lines showed greater mRNA
expression of Nox1, Rac1, p47phox, p67phox, NOXO1, and NOXA1
concomitant with increased superoxide generation [38]. Western
analysis of p47phox and p67phox of these lines is shown in Fig. 2B.
All Nox-derived cell lines lacked p47phox protein expression
suggesting that the Nox-derived cell lines may utilize NOXA to
replace p47phox‘s function. While other cobblestone lines
expressed p67phox, the spindle NuB1 and FIB cells did not express
p67phox indicating that these cells may utilize NOXO1 instead
of p67phox for Nox1 activation. This ﬁnding gives insights into
Fig. 2. Expression levels of cell cycle, cell survival and Nox1 adapter proteins among spindle and cobblestone cells. (A) NuB1 cells expressed p16INK4a (top), and survivin
(bottom) at higher levels than other cobblestone cell lines and FIB cells. Right 2 panels show quantiﬁcation of p16INK4a/β-actin and survivin//β-actin ratio among
3 cobblestone and 2 spindle cell lines. (B) Western blot analyses of p47phox (top) and p67phox (bottom) show the absence of p47phox in all Nox lines, while p67phox was
absent only in spindle NuB1 and FIB cells. A right panel shows quantiﬁcation of p67phox/β-actin ratio among 3 cobblestone and 2 spindle cell lines.
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speciﬁcity towards NOXA1 for preneoplastic epithelial cobblestone
cells, and that towards NOXO1 for spindle elongated FIB and NuB1
cells for Nox1 activation [41–43].
Epithelial mesenchymal transition (EMT)
of Nox1-preneoplastic cells
Two sets of cell lines were hence generated as model systems
to study an impact of Nox1 on neoplastic progression – EPI and FIB
from chronic ethanol exposure [23,36,37], and ﬁve Nox1 cell lines
with spindle NuB1 cells from Nox1 overexpression [38]. The
spindle FIB and NuB1 cells exhibiting EMT were compared with
their control counterparts. Our more recent data demonstrate the
progressive steps of FIB and NuB1 cells in cell migration, invasion,
and metastatic potentials.
Nox1 overexpression causes branching tubulogenic potential
previously reported for sinusoidal endothelial cells [44]. Branching
morphogenesis is commonly used to characterize breast and
prostate cancer cells. Upon resistance against Matrigel-induced
differentiation, FIB and NuB1 cells formed branching tubulogen-
esis with cords lacking lumen, while corresponding cobblestone
cells did not [44,45]. Using invasion/migration Boyden chamber,
FIB and NuB1 cells were more invasive with increased migratory
capacity than control cobblestone cell lines [45,46].
EMT of FIB and NuB1 cells was associated with the loss of
epithelial marker E-cadherin as well as the gain of mesenchymal
marker vimentin and fetal-type intermediate ﬁlament cytokera-
tins (CK) 8 and 18 [23,36,37,38]. We also demonstrated that EMT of
FIB and NuB1 cells involved increased expression of myoﬁbroblast
proteins, namely, vimentin, alpha-smooth muscle actin as well as
muscle and non-muscle caldesmon [46]. Hence, neoplastic trans-
formation of immortalized mucosal gingival epithelial cells
involves epithelial myoﬁbroblast transition to be included into
the ‘EMT’ deﬁnition. We further reported that cellular contractility
of spindle FIB and NuB1 cells was increased compared with that of
cobblestone cells [46]. Myocyte enhancing factor 2B (MEF2B) is the
only MEF2 isoform which is expressed during early embryonic
development, and it may transactivate downstream target EMT
proteins. Expression of MEF2B mRNA and myoﬁbroblast proteins
was higher in spindle NuB1 and FIB cells compared to cobblestone
cells. EGF treatment of cobblestone control cells also induced
expression of these genes. Knockdown of MEF2B in a cobblestone
cell line abolished EGF-induced upregulation of MEF2, vimentin
and non-muscle caldesmon proteins [37]. Thus, our work provides
an additional mechanism that EMT of immortalized gingival
epithelial cells may involve activation of MEF2B associated with
myogenic phenotype.
ROS are known to regulate proteins that are important for
degradation of extracellular matrices, such as, gelatinase matrix
metalloproteinases (MMP)-2, -9, which are key enzymes for
degrading type IV collagen and thought to play a critical role in
tumor invasion and metastasis. We showed that EPI cells secreted
latent MMP-9 (92 kDa) and MMP-2 (72 kDa) [47]. FIB cells released
a protein at 86 kDa with a slight lower molecular weight than
latent MMP-9 [45,47]. MMP-9 at 86 kDa is known as an inter-
mediate after ﬁrst cleavage of latent MMP-9 by MMP-3. Thus, FIB
cells secrete partially active MMP-9 by the action of stromelysin
MMP-3, and the implication of MMP-3 in FIB cells is consistent
with the role of ROS-induced MMP-3 in EMT induction and
genomic instability.
Regulation of intermediate ﬁlaments by Nox1
In an association with EMT, we extensively studied expression
and regulation of intermediate ﬁlaments in FIB and NuB1 cells.
These cells strongly expressed vimentin protein while correspond-
ing cobblestone cells expressed nearly undetectable vimentin
[23,36,37]. Similar to cancer Caco-2 cells, NuB1 and FIB cells
strongly expressed CK8 and CK18 while other Nox lines expressed
weaker CK18 [38]. Because simple or fetal keratins, such as, CK8/
CK18 are associated with malignant progression in different types
of ras-induced mouse keratinocytes [48], and human epithelial
tumors [49,50], our data demonstrate that Nox1 accelerates
neoplastic-like progression by regulating CK.
We showed that the parental immortalized GM16 cells cultured
in KGM expressed very weak CK18 compared with Nox1 lines, such
as cobblestone NuB2 cells cultured in DMEM [51]. In order to gain
insights into how Nox1 regulate CK8/CK18, we performed over-
expression of GM16 cells with Nox1-, control-, and Nox1-truncated
variant (Nox1-tv) plasmids in KGM. We found that Nox1 plasmid
increased CK18 protein, but not CK18 mRNA [51]. Alternatively, NuB2
cells cultured in DMEMwere used in Nox1-knockdown experiments.
Again, the knockdown decreased CK18 protein, but not CK18 mRNA.
More relevantly, antioxidant N-acetyl-L-cysteine as well as Nox
inhibitor diphenyleneiodonium or apocynin decreased CK18 protein
expression in NuB2 cells indicating redox regulation involving Nox1.
Thus, increased Nox1 induces accumulation of CK18 protein in a
redox-dependent manner.
We further showed that Nox1 in a redox-dependent manner
inhibited CK18 degradation at post-translational level as evi-
denced by CK18 accumulation upon proteasome inhibitor MG132
treatment. Furthermore, we showed that the increased CK18
protein expression in Nox1-overexpressed GM16 cells was con-
comitant with increased phosphorylation of CK18 at serine 52
(pS52CK18). The opposite was found upon Nox1-knockdown of
NuB2 cells showing decreases of both CK18 and pS52CK18. By
immunoprecipitation assay, we showed that Nox1 knockdown or
treatment of NuB2 cells with diphenyleneiodonium accumulated
the levels of ubiquinated CK18. This enhanced degradation thus
causing decreased CK18 protein. We hence have provided strong
evidence for post-translational regulation of CK18 by Nox1 invol-
ving phosphorylation and ubiquitination [51].
Role of PKCepsilon in CK18 accumulation by Nox1
It has been known that NADPH oxidase enzymes can be activated
by beta-, delta- and epsilon PKC isotypes [52]. In this context,
PKCepsilon has been shown to associate with and phosphorylate
CK18 [53], and thus PKCepsilon was proposed to be a signaling
molecule that regulates CK18 at post-translational level in Nox1-
expressing cells. We here show new results: treatment of NuB2 cells
with a PKC inhibitor Gö6983 decreased expression of CK18 protein in
cells alone or upon activation with PKC activator PMA (Fig. 3A).
Gö6983 or PKCepsilon siRNA concomitantly inhibited EGF-induced
ROS generation (Fig. 3B). Transfection of NuB2 cells with PKCepsilon
siRNAs decreased expression of CK18 protein when compared with
control siRNA (Fig. 3C). We therefore provide new evidence that
PKCepsilon could be a mediator of Nox1 and ROS which regulate a
post-translational accumulation of CK18.
Thus, our data showed that CK18 phosphorylation at ser-52 was
dependent on Nox1, PKC and ROS. These events may lead to
cytoskeletal dynamics associated with the reorganization of keratin
ﬁlaments in cell division. In Nox1-expressing cells, PKCepsilon may be
a key kinase as it is able to phosphorylate CK18 [53]. As depicted in
Fig. 3D, ligation of EGF tyrosine kinase receptor during cell growth
activates PKCepsilon leading to Nox1 activation and oxidant genera-
tion. PKCepsilon alone or Nox1-mediated oxidants may induce phos-
phorylation of CK18. This prevents CK18 from being ubiquinated
resulting in decreased Ub-CK18 thereby increased CK18 accumulation.
The use of DPI, apocynin, NAC, Gö6983, and PKCepilon siRNAwas able
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to reverse the processes resulting in decreased CK18 protein levels.
Phosphorylation of CK18 at ser-52 by PKCepsilon-mediated Nox1
activation may be an important key step in determining the levels of
CK18 subjected for ubiquination (Fig. 3D). PKCepsilon is shown to
increase cell growth and inhibits apoptosis [54] in human HaCaT
keratinocytes which express Nox1. While Nox1 is activated by Ras in
human colon cancer, PKCepsilon has also been shown to interact
with ras signaling pathway in colon epithelial cells [55]. PKCepsilon
has been shown to advance progression of human prostate cancer
[56], which highly expresses Nox1. PKCepsilon not only regulates
CK18 as demonstrated in our studies, it also regulates vimentin [57]
and actin [58] in the control of cell motility and ﬁber organization.
PKCepsilon may be considered an effector molecule of Nox-based
enzymes, particularly Nox1, in promoting transformation progres-
sion of and cancer cells for CK18 stabilization in a PKCepsilon-, ROS-
and phosphorylation-dependent manner. This post-translational
mechanism for CK18 accumulation is consistent with the persistent
presence of CK18 in many epithelial carcinomas. Our data also
indicate that PKCepsilon is an important mediator that contributes
to CK18 persistence, proliferation and apoptosis resistance in Nox1-
expressing cells. Nox1 and PKCepsilonmay thus be used as targets to
inhibit the progression of preneoplastic and cancer cells.
Role of Nox1 in accelerating transformation beyond
immortalization steps
To study the role of Nox1 and Nox1-derived ROS in human
epithelial cancers, we accomplished our goals in establishing pre-
neoplastic model cells from HPV16-immortalized gingival mucosal
cells by chronic ethanol or by Nox1 overexpression. Phenotypic
characterization of resultant cell lines indicates progressive steps in
cell transformation with spindle cells at higher steps than cobble-
stone epithelial cells. Spindle cells associated with EMT are likely
more migratory and invasive. Molecular targets of Nox1 involve
p16INK4a, survivin, MMP, MEF2B, CK18, and PKCepsilon, while the
latter three regulate EMT. Taken together, Nox1 mediates the
progression of immortalized human epithelial cells towards tumor-
igenicity partly by an induction of EMT. In human epithelial cancers,
Fig. 3. Impact of PKCepsilon on CK18 protein expression in a cobblestone NuB2 cells. (A) Treatment of NuB2 cells with 1 μM a pan PKC inhibitor Gö6983 for 6, 18 or 30 h
decreased CK18 protein expression (left panel). Increases of CK18 protein upon treatment of NuB2 cells with 500 nM PKC activator phorbol 12-myristate 13-acetate (PMA)
were inhibited by 1 μM Gö6983 after 1, 3 and 6 h (right panel). (B) Gö6983 treatment inhibited EGF-induced ROS generation (left panel). EGF treatment of NuB2 cells
increased ROS generation in mock- and control siRNA-transfected cells. PKCepsilon siRNA-transfection abolished these increases (right panel). (C) PKCepsilon siRNA-
transfected NuB2 cells for 24 h expressed decreased CK18 protein compared with control siRNA used at 50 nM (top panel). Quantiﬁcation of CK18 protein from 3 different
PKCepsilon siRNAs showed signiﬁcant decreases of CK18 compared with control siRNA transfection. (D) Proposed mechanism for stabilization of CK18 by Nox1 in a
PKCepsilon, ROS, and CK18 phosphorylation-dependent manner. EGF triggers PKCepsilon signaling for Nox1 to generate ROS which induce increased phosphorylation of
CK18. This leads to the decreased levels of CK18 which are subjected for ubiquitination and degradation, resulting in increased CK18 accumulation. Our experiments using
Gö6983, antioxidant, Nox inhibitor or PKCepsilon siRNA have proven that this CK18 accumulation is inhibited.
A. Sattayakhom et al. / Redox Biology 2 (2014) 140–147 145
Nox1 may be functional together with other oncogenes in accel-
erating neoplastic progression.
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